Who Exports Hydrochlorothiazide from India — 403 Suppliers Behind a $406.8M Market
India's hydrochlorothiazide export market is supplied by 403 active exporters who collectively shipped $406.8M across 6,947 shipments. UNICHEM LABORATORIES LIMITED leads with a 60.8% market share, followed by MACLEODS PHARMACEUTICALS LTD and MYLAN LABORATORIES LIMITED. The top 5 suppliers together control 83.1% of total export value, reflecting a concentrated market structure.
Top Hydrochlorothiazide Exporters from India — Ranked by Export Value
UNICHEM LABORATORIES LIMITED is the leading hydrochlorothiazide exporter from India, holding a 60.8% share of the $406.8M market across 6,947 shipments from 403 exporters. The top 5 suppliers — UNICHEM LABORATORIES LIMITED, MACLEODS PHARMACEUTICALS LTD, MYLAN LABORATORIES LIMITED, MICRO LABS LIMITED, IPCA LABORATORIES LIMITED — collectively control 83.1% of total export value, indicating a highly concentrated market. Individual shares are: UNICHEM LABORATORIES LIMITED (60.8%), MACLEODS PHARMACEUTICALS LTD (12.1%), MYLAN LABORATORIES LIMITED (6.4%), MICRO LABS LIMITED (2.0%), IPCA LABORATORIES LIMITED (1.8%).
Top Hydrochlorothiazide Exporters from India
Ranked by export value · 403 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | UNICHEM LABORATORIES LIMITED HYDROCHLOROTHIAZIDE TABLETS USP 25MG BOTTLE OF 1000THYDROCHLOROTHIAZIDE 50MG TAB - 100T BOTTLE OF 100TRAMIPRIL AND HYDROCHLOROTHIAZIDE TABLETS | $247.3M | 2 | 60.8% |
| 2 | MACLEODS PHARMACEUTICALS LTD HYDROCHLOROTHIAZIDE TABLETS USP 25MG BOTTLE OF 1000TIRBESARTAN / HYDROCHLOROTHIAZIDE MYLAN 3HYDROCHLOROTHIAZIDE 50MG TAB - 100T BOTTLE OF 100T | $49.0M | 29 | 12.1% |
| 3 | MYLAN LABORATORIES LIMITED IRBESARTAN / HYDROCHLOROTHIAZIDE MYLAN 3VALSARTAN AND HYDROCHLOROTHIAZIDE TABLETIRBESARTAN / HYDROCHLOROTHIAZIDE MYLAN 1 | $26.1M | 7 | 6.4% |
| 4 | MICRO LABS LIMITED ARISTO TELVAS H 80/12.5ARISTO TELVAS H 40/12.5IRBESARTAN / HYDROCHLOROTHIAZIDE MYLAN 3 | $8.3M | 27 | 2.0% |
| 5 | IPCA LABORATORIES LIMITED HYDROCHLOROTHIAZIDE TABLETS USP 25MG BOTTLE OF 1000TARISTO TELVAS H 80/12.5ARISTO TELVAS H 40/12.5 | $7.4M | 12 | 1.8% |
| 6 | LUPIN LIMITED CARDIZ CO 40/12.5MG INNOVAT_ZAZHTZWISE 25 (HYDROCHLOROTHIAZIDE TABLETS | $6.2M | 2 | 1.5% |
| 7 | ARISTO PHARMACEUTICALS PRIVATE LIMITED ARISTO TELVAS H 80/12.5ARISTO TELVAS H 40/12.5AMLOZAAR H TAX IN | $5.2M | 10 | 1.3% |
| 8 | AUROBINDO PHARMA LIMITED HYDROCHLOROTHIAZIDE TABLETS USP 25MG BOTTLE OF 1000TIRBESARTAN / HYDROCHLOROTHIAZIDE MYLAN 3HYDROCHLOROTHIAZIDE 50MG TAB - 100T BOTTLE OF 100T | $4.9M | 6 | 1.2% |
| 9 | CAPLIN POINT LABORATORIES LIMITED AMILORIDE HCL+HYDROCHLOROTHIAZIDE 5MG+50(HYDROCHLOROTHIAZIDE TABLETS BP 50MG | $4.1M | 6 | 1.0% |
| 10 | WATSON PHARMA PRIVATE LIMITED | $4.1M | 3 | 1.0% |
| 11 | MACLEODS PHARMACEUTICALS LIMITED HYDROCHLOROTHIAZIDE TABLETS USP 25MG BOTTLE OF 1000TIRBESARTAN / HYDROCHLOROTHIAZIDE MYLAN 3HYDROCHLOROTHIAZIDE 50MG TAB - 100T BOTTLE OF 100T | $3.9M | 21 | 1.0% |
| 12 | SUN PHARMACEUTICAL INDUSTRIES LIMITED HYDROCHLOROTHIAZIDE TABLETS USP 25MG BOTTLE OF 1000THYDROCHLOROTHIAZIDE 50MG TAB - 100T BOTTLE OF 100TAMLOZAAR H TAX INV | $3.4M | 7 | 0.8% |
| 13 | AUROBINDO PHARMA LTD HYDROCHLOROTHIAZIDE TABLETS USP 25MG BOTTLE OF 1000TIRBESARTAN / HYDROCHLOROTHIAZIDE MYLAN 3HYDROCHLOROTHIAZIDE 50MG TAB - 100T BOTTLE OF 100T | $3.2M | 8 | 0.8% |
| 14 | TORRENT PHARMACEUTICALS LTD CARDIZ CO 40/12.5MG INNOVAT_ZAZOTHER-CANDESARTAN /HCT HEUMANN 32MG/12.5MG TABLETTENHTZWISE 25 (HYDROCHLOROTHIAZIDE TABLETS | $3.1M | 8 | 0.8% |
| 15 | ALEMBIC PHARMACEUTICALS LIMITED HYDROCHLOROTHIAZIDE TABLETS USP 25MG BOTTLE OF 1000THYDROCHLOROTHIAZIDE 50MG TAB - 100T BOTTLE OF 100TCARDIZ CO 40/12.5MG INNOVAT_ZAZ | $3.1M | 7 | 0.8% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Hydrochlorothiazide exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| UNICHEM LABORATORIES LIMITED | Approved | Yes | Yes | 45 | Unichem has over 70 US ANDA filings, with 45 approved, and more than 60 European |
| MACLEODS PHARMACEUTICALS LTD | Approved | Yes | Yes | Unknown | Macleods is listed among top pharmaceutical companies with significant revenue. |
| MYLAN LABORATORIES LIMITED | Approved | Yes | Yes | Unknown | Received FDA warning letter for CGMP deviations related to nitrosamine impuritie |
| MICRO LABS LIMITED | Approved | Yes | Yes | Unknown | Micro Labs is a significant exporter of Hydrochlorothiazide. |
| IPCA LABORATORIES LIMITED | Approved | Yes | Yes | Unknown | IPCA Laboratories is a notable exporter of Hydrochlorothiazide. |
| LUPIN LIMITED | Approved | Yes | Yes | Unknown | Received FDA warning letter for CGMP violations. |
| AUROBINDO PHARMA LIMITED | Approved | Yes | Yes | Unknown | Received FDA warning letter for GMP issues related to nitrosamine contaminants. |
| TORRENT PHARMACEUTICALS LTD | Approved | Yes | Yes | Unknown | Received FDA warning letter for CGMP violations related to nitrosamine impuritie |
| ALEMBIC PHARMACEUTICALS LIMITED | Approved | Yes | Yes | Unknown | Alembic Pharmaceuticals is a significant exporter of Hydrochlorothiazide. |
TransData Nexus reviewed the regulatory standing of 9 leading Hydrochlorothiazide exporters from India. 9 hold US FDA facility approvals, 9 maintain WHO-GMP certification, and 9 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Hydrochlorothiazide sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," hosts numerous Active Pharmaceutical Ingredient (API) manufacturers. The city's well-established infrastructure and supportive regulatory environment make it a pivotal hub for the production of APIs like Hydrochlorothiazide. Companies in this region benefit from proximity to research institutions and a skilled workforce, facilitating efficient production and innovation.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its pharmaceutical formulations industry. This region is home to several leading pharmaceutical companies specializing in the production of finished dosage forms, including Hydrochlorothiazide tablets. The presence of state-of-the-art manufacturing facilities and adherence to international quality standards have positioned this cluster as a significant contributor to India's pharmaceutical exports.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a crucial export gateway for pharmaceutical products. With its strategic location near major ports and airports, this region facilitates the efficient export of pharmaceuticals, including Hydrochlorothiazide, to global markets. The concentration of regulatory bodies and export-oriented units further enhances its role in the supply chain.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi-Nalagarh in Himachal Pradesh has emerged as a prominent pharmaceutical manufacturing zone, largely due to favorable tax incentives and a conducive business environment. This region attracts numerous pharmaceutical companies focusing on cost-effective production of various drugs, including Hydrochlorothiazide, thereby contributing significantly to both domestic supply and exports.
5Sourcing Recommendations
- Diversify Supplier Base: Engage with multiple suppliers across different clusters to mitigate risks associated with regional disruptions.
- Assess Regulatory Compliance: Ensure that suppliers adhere to international quality standards and possess necessary certifications from regulatory bodies such as the FDA, EMA, and WHO.
- Evaluate Export Capabilities: Prioritize suppliers with established export credentials, particularly those with a strong presence in key markets like the United States and Canada.
- Monitor Market Dynamics: Stay informed about changes in tax incentives, regulatory policies, and infrastructure developments within these clusters to make informed sourcing decisions.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Hydrochlorothiazide exporters from India
Ipca Laboratories Limited — Ipca Laboratories acquires 33.38% stake in Unichem Laboratories
In April 2023, Ipca Laboratories Limited acquired 2,35,01,440 fully paid-up equity shares of ₹2 each, constituting 33.38% of the fully diluted voting share capital of Unichem Laboratories Limited, from Dr. Prakash Mody, Promoter & Director, at a price of ₹402.25 per equity share. - IMPACT: This acquisition is expected to enhance Ipca's manufacturing capabilities and market reach, potentially increasing Hydrochlorothiazide exports.
Impact: This acquisition is expected to enhance Ipca's manufacturing capabilities and market reach, potentially increasing Hydrochlorothiazide exports.
Ipca Laboratories Limited — Ipca Laboratories increases stake in Unichem Laboratories to 52.67%
On September 21, 2023, Ipca Laboratories Limited acquired an additional 1,35,79,571 equity shares at ₹440 per share through an open offer, raising its total holding in Unichem Laboratories to 52.67% of the total paid-up equity share capital. - IMPACT: With majority control over Unichem, Ipca is positioned to streamline operations and expand its Hydrochlorothiazide export capacity.
Impact: With majority control over Unichem, Ipca is positioned to streamline operations and expand its Hydrochlorothiazide export capacity.
Unichem Laboratories Limited — Unichem Laboratories transfers stake in Irish subsidiary to Ipca Laboratories
In April 2025, Unichem Laboratories Limited transferred its 100% stake in its wholly owned subsidiary, Unichem Laboratories Limited, Ireland, to its holding company, Ipca Laboratories Limited. - IMPACT: This internal restructuring may lead to more efficient operations and potentially boost Hydrochlorothiazide exports.
Impact: This internal restructuring may lead to more efficient operations and potentially boost Hydrochlorothiazide exports.
Common Questions — Hydrochlorothiazide Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which hydrochlorothiazide supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, UNICHEM LABORATORIES LIMITED leads with 425 recorded shipments worth $247.3M. MACLEODS PHARMACEUTICALS LTD (509 shipments) and MYLAN LABORATORIES LIMITED (329 shipments) are also established high-volume exporters.
Q How many hydrochlorothiazide manufacturers are there in India?
India has 403 active hydrochlorothiazide exporters with a combined export market of $406.8M across 6,947 shipments to 149 countries. The top 5 suppliers hold 83.1% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for hydrochlorothiazide from India?
Average FOB unit price: $7.00 per unit, ranging from $0.00 to $2752.71. Average shipment value: $58.6K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 403 verified Indian exporters of Hydrochlorothiazide ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 6,947 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 149 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
6,947 Verified Shipments
403 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists